NH-1,2,3-Triazole Inhibitors of the VIM-2 Metallo-β-Lactamase

被引：83

作者：

Weide, Timo ^{[2
]}

Saldanha, S. Adrian ^{[1
]}

Minond, Dmitriy ^{[1
]}

Spicer, Timothy P. ^{[1
]}

Fotsing, Joseph R. ^{[2
]}

Spaargaren, Michael ^{[1
]}

Frere, Jean-Marie ^{[3
]}

Bebrone, Carine ^{[3
]}

Sharpless, K. Barry ^{[2
]}

Hodder, Peter S. ^{[1
]}

Fokin, Valery V. ^{[2
]}

机构：

[1] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA

[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA

[3] Univ Liege, Ctr Prot Engn, B-4000 Liege, Belgium

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2010年 / 1卷 / 04期

基金：

美国国家卫生研究院;

关键词：

Metallo-beta-lactamases; VIM-2; NH-1,2,3-triazole-based inhibitors; bacterial resistance; Escherichia coli;

D O I：

10.1021/ml900022q

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Metallo-beta-lactamases (MBLs) are an emerging cause of bacterial resistance to antibiotic treatment. The VIM-2 beta-lactamase is the most commonly encountered MBLs in clinical isolates worldwide. Described here are potent and selective small molecule inhibitors of VIM-2 containing the arylsulfonyl-NH-1,2,3-triazole chemotype that potentiate the efficacy of the beta-lactam, imipenem, in Escherichia coli.

引用

页码：150 / 154

页数：5

共 50 条

[1] Characterization of metallo-β-lactamase VIM-2
Bergstrom, Alex
Aitha, Mahesh
Sanyurah, Omar
Moritz, Lindsay
Turner, Lucien
Tierney, David L.
Crowder, Michael W.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[2] Identification and Validation Novel of VIM-2 Metallo-β-lactamase Tripeptide Inhibitors
Xiao, Jing
Fang, Mi
Shi, Yun
Chen, Hui
Shen, Bingzhen
Chen, Jiao
Lao, Xingzhen
Xu, Hanmei
Zheng, Heng
MOLECULAR INFORMATICS, 2015, 34 (08) : 559 - 567
[3] VIM-2 metallo-β-lactamase in Achromobacter xylosoxidans in Europe
D. Sofianou
A. Markogiannakis
E. Metzidie
S. Pournaras
A. Tsakris
European Journal of Clinical Microbiology and Infectious Diseases, 2005, 24 : 854 - 855
[4] VIM-2 metallo-β-lactamase in Achromobacter xylosoxidans in Europe
Sofianou, D
Markogiannakis, A
Metzidie, E
Pournaras, S
Tsakris, A
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (12) : 854 - 855
[5] Arginine-containing peptides as potent inhibitors of VIM-2 metallo-β-lactamase
Rotondo, Caitlyn M.
Marrone, Laura
Goodfellow, Valerie J.
Ghavami, Ahmad
Labbe, Genevieve
Spencer, James
Dmitrienko, Gary I.
Siemann, Stefan
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2015, 1850 (11): : 2228 - 2238
[6] Biochemical, Mechanistic, and Spectroscopic Characterization of Metallo-β-lactamase VIM-2
Aitha, Mahesh
Marts, Amy R.
Bergstrom, Alex
Moller, Abraham Jon
Moritz, Lindsay
Tumer, Lucien
Nix, Jay C.
Bonomo, Robert A.
Page, Richard C.
Tierney, David L.
Crowder, Michael W.
BIOCHEMISTRY, 2014, 53 (46) : 7321 - 7331
[7] The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor
Christopeit, Tony
Yang, Ke-Wu
Yang, Shao-Kang
Leiros, Hanna-Kirsti S.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2016, 72 : 813 - 819
[8] Detection of VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Germany
Henrichfreise, B
Wiegand, I
Sherwood, KJ
Wiedemann, B
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1668 - 1669
[9] Inhibiting the VIM-2 Metallo-β-Lactamase by Graphene Oxide and Carbon Nanotubes
Huang, Po-Jung Jimmy
Pautler, Rachel
Shanmugaraj, Jenitta
Labbe, Genevieve
Liu, Juewen
ACS APPLIED MATERIALS & INTERFACES, 2015, 7 (18) : 9898 - 9903
[10] VIM-2 metallo-β-lactamase emerges in Pseudomonas aeruginosa isolated from India
Toleman, M. A.
Vinodh, H.
Sekar, U.
Vijaylakshmi, K.
Walsh, T. R.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S107 - S107

← 1 2 3 4 5 →